BioSpace News Archive

Senator Ron Johnson (R-Wis.), Chairman of the Homeland Security and Governmental Affairs Committee, along with Sen. Mike Lee (R-Utah) and Sen. Ted Cruz (R-Texas), in a letter to Food and Drug Administration (FDA) Commissioner Stephen Hahn, write that “the FDA’s actions regarding [hydroxychloroquine] HCQ may be directly costing lives by limiting outpatient access to this potentially beneficial treatment.”

Medicure Inc. (" Medicure " or the " Company ") (TSXV: MPH) (OTC: MCUJF), a pharmaceutical company, today announced the termination of the marketing and distribution agreement with Sensible Medical Innovations Inc. (" Sensible

CENTOGENE AND EVOTEC INTEND TO IDENTIFY NOVEL DISEASE-MODIFYING TARGETS FIRST TARGET SELECTED FOR THE DEVELOPMENT OF A THERAPEUTIC CANDIDATE CENTOGENE CONTRIBUTES ACCESS TO ITS GLOBAL PROPRIETARY RARE DISEASE PLATFORM, EVOTEC WILL LEVERAGE ITS PROPRIETARY IPSC PLATFORM AND DRUG DISCOVERY AND DEVELOPMENT EXPERTISE HAMBURG and ROSTOCK, GERMANY / ACCESSWIRE / August 20, 2020 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) and CENTOGENE N.V. (Nasdaq:CNTG

Approval broadens DARZALEX label to include fifth treatment option in the relapsed/refractory setting and represents the eighth approved indication for DARZALEX [20-August-2020] HORSHAM, Pa. , Aug. 20, 2020 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. Food and Drug Administration (FDA) approval of DARZALEX ® (

ForDoz Pharma has entered into an agreement with Lupin, to market and distribute 2 complex injectable products in advanced development stage at ForDoz, in US and its territories. The products are in the Oncology and Anti-infective therapeutic areas which when approved, will provide affordable alternatives to patients and healthcare professionals. These two licensed products are flagship technology assets among ForDoz complex injectable pr

Celularity, Inc. (“Celularity” or “the Company”) today announced that it has sold its UltraMIST® Ultrasound Healing Therapy asset to Sanuwave Health, Inc. [OTC PNK: SNWV] (“Sanuwave”) in connection with which Celularity granted Sanuwave certain partnership rights to the Company’s wound care biologic product portfolio.

In the new role, Dr. Gebow will advance software development and data analytics innovation across Medical Imaging and Clinical Adjudication

Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced it has signed an exclusive global distribution agreement with ADS Biotec for the sale and distribution of its proprietary IV-Cell cytogenetics cell culturing media.

Self-collected saliva and deep nasal swabs collected by healthcare providers are equally effective for detecting SARS-CoV-2, the virus that causes COVID-19, according to a new study conducted by ARUP Laboratories and University of Utah (U of U) Health.

NeuroMetrix, Inc. (Nasdaq: NURO) today announced that its Quell device will be used in an NIH-funded, multi-site randomized controlled trial (RCT) of the efficacy of transcutaneous electrical nerve stimulation (TENS) for chemotherapy-induced peripheral neuropathy (CIPN).